子生育和女性生育能力的保护:临床更新
1Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio.
概括
癌症治疗可以通过减少卵子供应来损害生育能力. 诸如胚胎,卵细胞和卵巢组织冷保存等生育保存选择有助于妇女在医疗治疗期间保持生殖潜力.
科学领域:
- 在生育能力上.
- 生殖内分泌学 生殖内分泌学
- 在瘤学瘤学.
背景情况:
- 癌症治疗,包括化疗和放射治疗,可能会对卵巢储备产生负面影响,并导致过早的卵巢衰竭.
- 生育风险受患者年龄,基线卵巢储备和特定治疗方案 (药物,剂量) 的影响.
- 瘤生育解决了癌症患者的生殖问题,旨在在治疗期间保持生育能力.
研究的目的:
- 审查正在接受对卵巢功能构成风险的医疗治疗的妇女的生育保护策略.
- 突出在癌症治疗的背景下维持生殖潜力的关键选择.
主要方法:
- 审查与医疗治疗相关的已建立的生育保存技术.
- 讨论冷保存方法:胚胎,卵细胞和卵巢组织.
- 考虑手术干预,如卵巢和子宫转移用于盆腔辐射.
主要成果:
- 保护生育能力为那些有治疗引起的卵巢缺陷风险的妇女提供了可行的选择.
- 胚胎,卵细胞或卵巢组织的冷保存是医疗治疗场景的主要方法.
- 对于接受盆腔放射治疗的患者来说,外科移植技术是很重要的.
结论:
- 面临性腺毒性癌症治疗的女性有多种生育保护选择.
- 胚胎,卵细胞和卵巢组织的冷保存对于保持生育能力至关重要.
- 对于接受威胁生殖能力的医疗治疗的妇女来说,性生育管理是必不可少的.
相关概念视频
Infertility in Females
406
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
406
Infertility in Males
337
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
337
In Vitro Fertilization
415
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
415
Hormonal Control of the Ovarian Cycle
3.3K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
3.3K
Oogenesis
64.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
64.5K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


